Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
New cancer study findings have been reported from M.L. Hensley et al
February 19th, 2009
According to a study from the United States, " To update a clinical practice guideline on the use of chemotherapy and radiation therapy protectants for patients with cancer. An update committee reviewed literature published since the last guideline update in 2002." " Thirty-nine reports met the inclusion criteria: palifermin and dexrazoxane, three reports ( two studies) each; amifostine, 33 reports ( 31 studies); and mesna, no published randomized trials identified since 2002. Dexrazoxane is not recommended for routine use in breast cancer ( BC) in adjuvant setting, or metastatic setting with initial doxorubicin-based chemotherapy. Consider use with metastatic BC and...
Source: Women's Health Weekly (2009-02-19)
|
